NAM member Elaine Fuchs, Rebecca C. Lancefield Professor, Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, has been honored with the 2017 McEwen Award for Innovation. The prize, given by the International Society for Stem Cell Research, recognizes original thinking and transformative, ground-breaking research pertaining to stem cells or regenerative medicine that opens new avenues of exploration towards the understanding or treatment of human disease or affliction. Dr. Fuchs will receive a $100,000 award and present her research at the society’s annual meeting in June. [space height=”10″]
Dr. Fuchs, who is also an investigator at Howard Hughes Medical Institute, studies the biology of skin stem cells. Her research has given insight into how stem cells maintain and differentiate and how errors in this process might lead to cancer. Fuchs has also pioneered the use of reverse genetics to understand the biological basis of normal and abnormal skin development and function.
Fuchs was elected to the National Academy of Medicine in 1994.
The International Society for Stem Cell Research is a nonprofit membership organization that was established in 2002 to promote the exchange of information and ideas related to stem cells. Now in its seventh year, the McEwen Award for Innovation, which is supported by the McEwen Centre for Regenerative Medicine in Toronto, Canada, recognizes research in stem cells or regenerative medicine that contributes to the understanding or treatment of human disease. To learn more about the McEwen Award for Innovation, please click here.
